The 30-day risks of hospitalization were 17.5%, 15.9%, and 14.4% for COVID, influenza, and RSV, respectively, during the 2022 ...

Respiratory Syncytial Virus (RSV) is a highly contagious respiratory illness that primarily affects infants and older adults, ...

RSV is usually contagious for three to eight days. A patient also may be contagious a day or two before experiencing symptoms ...

In the throes of winter's yearly round of respiratory virus outbreaks, it pays to remember what Grandma told you.

The study, published Jan. 20 in The Lancet Infectious Diseases, found the vaccine to be 78% effective against RSV infection, 79% effective against emergency department and urgent care visits and 80% ...

The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...

At the start of every week, our team talks with local experts to unpack a wide range of nationwide health, safety, and ...

As of Jan. 20, the CDC reports that RSV activity has peaked in most of the U.S., particularly among young children—a group ...

Winter also marks the height of the respiratory virus season, a period of sniffles, sneezes, congestion, fever and other ...

Inflammation can trigger heart attacks in people with coronary artery disease. It can also exacerbate heart failure symptoms ...

A virus rapidly spreading in China is also circulating in the United States, causing concern among health experts.

Human Metapneumovirus (HMPV) is a respiratory virus that may not be on most folk’s radars, but it’s more common than you ...